newscontact us

CESCA THERAPEUTICS REPORTS SECOND QUARTER FISCAL 2017 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE

Rancho Cordova, CA, February 13, 2017 – Cesca Therapeutics Inc. (NASDAQ: KOOL), a market
leader in automated cellular processing and point-of-care autologous cell-based therapies,
today reported second quarter financial results for 2017 and provided an update to investors…(more)